The seroprevalence of SARS-CoV-2 in patients on haemodialysis

Viyaasan Mahalingasivam, Laurie Tomlinson, Viyaasan Mahalingasivam, Laurie Tomlinson

Abstract

A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis populations, the findings should be interpreted with caution.

Conflict of interest statement

The authors declare no competing interests.

References

    1. Ward H, et al. Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. medRxiv. 2020 doi: 10.1101/2020.08.12.20173690.
    1. Pollán M, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396:535–544. doi: 10.1016/S0140-6736(20)31483-5.
    1. Anand S, et al. Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet. 2020;396:1335–1344. doi: 10.1016/S0140-6736(20)32009-2.
    1. Rosenberg ES, et al. Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York. Ann. Epidemiol. 2020;48:23–29. doi: 10.1016/j.annepidem.2020.06.004.
    1. Hiremath, S. et al. Dialysis and CKD-summary of mortality from COVID-19 among dialysis patients. #NephJC (2020).
    1. The Renal Association. COVID-19 surveillance report for renal centres in the UK. The Renal Association (2020).
    1. Bel’eed K, Wright M, Eadington D, Farr M, Sellars L. Vaccination against hepatitis B infection in patients with end stage renal disease. Postgrad. Med. J. 2020;78:538–540. doi: 10.1136/pmj.78.923.538.
    1. Clarke C, et al. High prevalence of asymptomatic COVID-19 infection in hemodialysis patients detected using serologic screening. J. Am. Soc. Nephrol. 2020;31:1969–1975. doi: 10.1681/ASN.2020060827.
    1. Wajnberg A, et al. Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study. Lancet Microbe. 2020;1:283–289. doi: 10.1016/S2666-5247(20)30120-8.
    1. Alford, J. Coronavirus antibody prevalence falling in England, REACT study shows. Imperial College London (2020).

Source: PubMed

3
구독하다